Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

A vaccine to prevent breast cancer is showing good results, and moving into the next stage of clinical trials.

President Donald Trump’s pick to lead the National Institutes of Health answered sharp questions in a confirmation hearing ...

A University of Otago, Christchurch-led study is heralding the success of the HPV vaccination program, saying the cost and ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

Researchers have developed a cancer vaccine method that can target virtually any solid tumor, amplifying the visibility of ...

A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney ...

The study followed 16 patients, including Barbara Brigham, who joined the trial after a routine scan discovered her ...